Renaissance Technologies
TNGX icon

Renaissance Technologies’s Tango Therapeutics TNGX Stock Holding History

Renaissance Technologies’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-55,300
Closed -$465K – 3764
2025
Q3 		$465K Sell
55,300
-10,200
-16% -$69K ﹤0.01% 2828
2025
Q2 		$335K Sell
65,500
-109,000
-62% -$270K ﹤0.01% 3003
2025
Q1 		$239K Buy
174,500
+153,000
+712% +$376K ﹤0.01% 3011
2024
Q4 		$66.4K Buy
+21,500
New +$99.8K ﹤0.01% 3348
2024
Q2 		– Sell
-65,600
Closed -$521K – 3961
2024
Q1 		$521K Sell
65,600
-55,400
-46% -$594K ﹤0.01% 2846
2023
Q4 		$1.2M Buy
121,000
+82,800
+217% +$719K ﹤0.01% 2282
2023
Q3 		$430K Sell
38,200
-40,500
-51% -$247K ﹤0.01% 2781
2023
Q2 		$261K Buy
78,700
+17,800
+29% +$64K ﹤0.01% 3189
2023
Q1 		$241K Buy
60,900
+35,600
+141% +$207K ﹤0.01% 3203
2022
Q4 		$183K Buy
25,300
+14,100
+126% +$99.2K ﹤0.01% 3448
2022
Q3 		$41K Buy
+11,200
New +$47.8K ﹤0.01% 3802

Other funds holding TNGX

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies's TNGX Position: Q4 2025 in Review

Renaissance Technologies sold out of Tango Therapeutics (TNGX) in Q4 2025, closing a stake of 55,300 shares — an estimated $465K sold.

Renaissance Technologies first reported a position in TNGX in Q3 2022 and held it in 11 quarters. The position peaked at $1.2M in Q4 2023. 170 funds tracked by Wall St. Rank hold TNGX as of Q4 2025.

  • Renaissance Technologies reported no remaining Tango Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 55,300 Tango Therapeutics shares in Q4 2025, an estimated $465K.
  • Renaissance Technologies first reported a position in Tango Therapeutics in Q3 2022 and held it in 11 quarters.
  • Renaissance Technologies's Tango Therapeutics position peaked at $1.2M in Q4 2023.
  • 170 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.